Rox Medical

San Clemente, United States Founded: 2004 • Age: 22 yrs
Develops interventional vascular therapies.

About Rox Medical

Rox Medical was a Healthcare company based in San Clemente (United States) founded in 2004. It develops interventional vascular therapies. It operates on a B2B model. Rox Medical has raised $101.1 million across 7 funding rounds from investors including Novartis Venture Fund, Apple Tree Partners and Versant Ventures. The company has 6 employees. The company is recorded as dissolved. Its focus areas include Medical Devices, Vascular Therapy and Interventional. Its legal entity is ROX Medical, Inc. Its competitors include Third Pole Therapeutics, Valencia Technologies and Sympara Medical; 3 of its 3 listed competitors have raised funding.

Company details

Rox Medical, established in 2004 and currently in Dissolved stage, focuses on providing healthcare solutions, developing medical devices, vascular therapy, and interventional. Develops interventional vascular therapies. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters San Clemente, United States
  • Employees 6
  • Sectors
    Healthcare
  • Website roxmedical.com
  • Social X Facebook
  • Legal Name Rox Medical, Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $101.1M (USD)

    in 7 rounds

  • Latest Funding Round
    $40M (USD), Series E

    Sep 2016

  • Investors
  • Employee Count
    6

Funding Insights of Rox Medical

Rox Medical has successfully raised a total of $101.1M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $40 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $101.1M
  • Total Rounds 7
  • Last Round Series E β€” $40M
  • First Round $3.6M

    (Apr 2004)

  • Investors Count 6

All 7 funding rounds of Rox Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2016$40MSeries E––
Sep 2012$6MSeries D––
–
Aug 2011$4MSeries D––
–
Jun 2008$35MSeries C––
Apr 2008$2.4MSeries C––
–
Aug 2006$10.1MSeries B––
–
Apr 2004$3.6MSeries A––
–
Valuation history

6 investors in total: 6 institutional.

Investors in Rox Medical

Rox Medical has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Novartis Venture Fund, Apple Tree Partners and Versant Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investments are made in innovative life science companies globally.
nvfund.comBasel, Switzerland
Apple Tree Partners is engaged in life sciences venture capital.
appletreepartners.com
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
versantventures.com
Life science & tech focused VC firm investing in the US
domainvc.comPrinceton, United States
VC firm investing in the US
prismventure.comWestwood, United States
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
ewhealthcare.comNew York, United States
Premium access

Investor details for Rox Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Rox Medical

3 dated milestones of Rox Medical across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Rox Medical is founded.
  2. Funding First funding round of $3.6M.
  3. Funding Latest funding round, Series E, of $40.0M.

Competitors of Rox Medical

Rox Medical has 3 listed competitors in our database, 3 of them funded. They include Third Pole Therapeutics, Valencia Technologies and Sympara Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pole3.com2014Boston, United States$87.6M
Developer of devices for cardiopulmonary therapies
valenciatechnologies.com2011Santa Clarita, United States$54.97M
A coin-sized neuromodulation device for hypertension treatment is developed.
sympara.com2012San Francisco, United States$4.25M
Develops innovative medical devices for effective hypertension treatment.
Premium access

Detailed competitors of Rox Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cell Therapy

3 companies that operate in the same segment as Rox Medical (Cell Therapy) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
2013Seattle, Washington, United StatesUSD 316.67 M520
CAR-T and TIL immunotherapies for solid tumors are developed.
2018San Francisco, California, United StatesUSD 493 MUSD 36 K233
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Rox Medical

Premium access

Complete news archive for Rox Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rox Medical

Rox Medical was founded in 2004.

Rox Medical is headquartered in San Clemente, United States. It is registered at San Clemente, California, United States.

Rox Medical is a funded company, having raised a total of $101.1M across 7 funding rounds to date. The company's 1st funding round was a Series A of $3.6M, raised on Apr 2004.

Rox Medical has 6 employees.

Rox Medical, established in 2004 and currently in Dissolved stage, focuses on providing healthcare solutions, developing medical devices, vascular therapy, and interventional. Develops interventional vascular therapies. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

Rox Medical's top competitors include Valencia Technologies, Third Pole Therapeutics and Sympara Medical.

Rox Medical has 6 investors. Key investors include Novartis Venture Fund, Apple Tree Partners, Versant Ventures, Domain Associates, and Prism Venture Partners.

Rox Medical operates through Rox Medical, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available